Brooklyn ImmunoTherapeutics Announces Presentation of Ongoing Investigator Sponsored Trial of IRX-2 Regimen Combined with Nivolumab in Recurrent/Metastatic Solid Tumors

54

BROOKLYN, N.Y.–(BUSINESS WIRE)–Brooklyn ImmunoTherapeutics announces presentation of ongoing trial poster at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting…..

 

 

 

 

http://www.businesswire.com/news/home/20190603005744/en/Brooklyn-ImmunoTherapeutics-Announces-Presentation-Ongoing-Investigator-Sponsored

 

- Advertisement -